Effect of single-dose rituximab on primary glomerular diseases.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 20693810)

Published in Nephron Clin Pract on August 06, 2010

Authors

Hidekazu Sugiura1, Takashi Takei, Mitsuyo Itabashi, Misao Tsukada, Takahito Moriyama, Chiari Kojima, Toshiharu Shiohira, Ari Shimizu, Yuki Tsuruta, Nobuyuki Amemiya, Tetsuya Ogawa, Keiko Uchida, Ken Tsuchiya, Kosaku Nitta

Author Affiliations

1: Department of Medicine, Kidney Center, Tokyo Women's Medical University, Tokyo, Japan.

Articles citing this

Rituximab therapy in nephrotic syndrome: implications for patients' management. Nat Rev Nephrol (2013) 1.18

Rituximab for refractory cases of childhood nephrotic syndrome. Pediatr Nephrol (2011) 0.98

Biologics for the treatment of autoimmune renal diseases. Nat Rev Nephrol (2016) 0.97

Rituximab in adult patients with multi-relapsing/steroid-dependent minimal change disease and focal segmental glomerulosclerosis: a report of 5 cases. Wien Klin Wochenschr (2013) 0.82

Rituximab and minimal change nephrotic syndrome: a therapeutic option. Clin Exp Nephrol (2011) 0.82

Rituximab use in adult primary glomerulopathy: where is the evidence? Ther Clin Risk Manag (2016) 0.81

C3 Glomerulopathy. Pediatr Nephrol (2016) 0.76

Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy? Clin Exp Immunol (2016) 0.75

B cell-depleting therapy with rituximab or ofatumumab in immunoglobulin A nephropathy or vasculitis with nephritis. Clin Kidney J (2016) 0.75

American Society of Nephrology quiz and questionnaire 2013: glomerulonephritis. Clin J Am Soc Nephrol (2014) 0.75

Circulating (CD3(-)CD19(+)CD20(-)IgD(-)CD27(high)CD38(high)) Plasmablasts: A Promising Cellular Biomarker for Immune Activity for Anti-PLA2R1 Related Membranous Nephropathy? Mediators Inflamm (2016) 0.75

Update on immunoglobulin a nephropathy. Part II: Clinical, diagnostic and therapeutical aspects. World J Nephrol (2016) 0.75

Sequential therapy with cyclophosphamide and mycophenolic acid in patients with progressive immunoglobulin A nephropathy: a long-term follow-up. Clin Exp Immunol (2015) 0.75

Hepatocellular carcinoma following renal transplantation. Gastrointest Cancer Res (2011) 0.75

Articles by these authors

Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis (2009) 18.60

Molecular pathogenesis of pseudohypoaldosteronism type II: generation and analysis of a Wnk4(D561A/+) knockin mouse model. Cell Metab (2007) 2.88

Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan. Am J Kidney Dis (2007) 2.74

Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol (2007) 2.58

IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism. Science (2005) 2.53

Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol (2007) 2.20

Klotho reduces apoptosis in experimental ischaemic acute kidney injury via HSP-70. Nephrol Dial Transplant (2009) 1.75

The importance of low blood urea nitrogen levels in pregnant patients undergoing hemodialysis to optimize birth weight and gestational age. Kidney Int (2009) 1.64

Klotho reduces apoptosis in experimental ischaemic acute renal failure. Nephrol Dial Transplant (2005) 1.55

Generation and analyses of R8L barttin knockin mouse. Am J Physiol Renal Physiol (2011) 1.52

Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease. Clin Rheumatol (2014) 1.50

Urinary free light chain is a potential biomarker for ISN/RPS class III/IV lupus nephritis. Rheumatology (Oxford) (2013) 1.46

Oxidative stress decreases klotho expression in a mouse kidney cell line. Nephron Exp Nephrol (2005) 1.44

A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity. Clin Exp Nephrol (2009) 1.44

IgG4-related tubulointerstitial nephritis and lymphadenopathy after therapy for malignant lymphoma. Intern Med (2012) 1.42

Pretreatment with 5-FU enhances cisplatin cytotoxicity in head and neck squamous cell carcinoma cells. Cancer Chemother Pharmacol (2007) 1.41

P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines. Head Neck (2003) 1.40

Chronic Kidney Disease Japan Cohort study: baseline characteristics and factors associated with causative diseases and renal function. Clin Exp Nephrol (2010) 1.39

Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods. Hypertens Res (2008) 1.39

Histologic criteria for diagnosing encapsulating peritoneal sclerosis in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial (2003) 1.29

ANCA-associated systemic vasculitis in Japan: clinical features and prognostic changes. Clin Exp Nephrol (2012) 1.27

Potential roles of large mafs in cell lineages and developing pancreas. Pancreas (2006) 1.27

Left ventricular hypertrophy is associated with arterial stiffness and vascular calcification in hemodialysis patients. Hypertens Res (2004) 1.24

Immunolocalization of WNK4 in mouse kidney. Histochem Cell Biol (2011) 1.17

Reduced Klotho expression level in kidney aggravates renal interstitial fibrosis. Am J Physiol Renal Physiol (2012) 1.16

The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis. Am J Kidney Dis (2003) 1.13

Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors. Nephrol Dial Transplant (2009) 1.13

M(3) muscarinic acetylcholine receptor plays a critical role in parasympathetic control of salivation in mice. J Physiol (2004) 1.09

Pathogenesis and treatment of autosomal-dominant nephrogenic diabetes insipidus caused by an aquaporin 2 mutation. Proc Natl Acad Sci U S A (2006) 1.09

Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis. Am J Kidney Dis (2004) 1.08

Serum osteoprotegerin levels and the extent of vascular calcification in haemodialysis patients. Nephrol Dial Transplant (2004) 1.04

Clinical correlates of ambulatory BP monitoring among patients with CKD. Clin J Am Soc Nephrol (2013) 1.03

Epigenetic inactivation of galanin receptor 1 in head and neck cancer. Clin Cancer Res (2008) 1.02

Histological heterogeneity of glomerular segmental lesions in focal segmental glomerulosclerosis. Int Urol Nephrol (2011) 1.01

Tissue-preserving approach to extracting DNA from paraffin-embedded specimens using tissue microarray technology. Head Neck (2007) 1.01

Progression of aortic arch calcification and all-cause and cardiovascular mortality in chronic hemodialysis patients. Int Urol Nephrol (2009) 1.01

The regulatory domain of the inositol 1,4,5-trisphosphate receptor is necessary to keep the channel domain closed: possible physiological significance of specific cleavage by caspase 3. Biochem J (2004) 1.00

Management of anemia in chronic kidney disease patients: baseline findings from Chronic Kidney Disease Japan Cohort Study. Clin Exp Nephrol (2011) 0.99

Severity of nephrotic IgA nephropathy according to the Oxford classification. Int Urol Nephrol (2012) 0.99

ATF3 protects against renal ischemia-reperfusion injury. J Am Soc Nephrol (2008) 0.99

Successful use of single-dose rituximab for the maintenance of remission in a patient with steroid-resistant nephrotic syndrome. Intern Med (2009) 0.99

Japanese Society for Dialysis Therapy guidelines for management of cardiovascular diseases in patients on chronic hemodialysis. Ther Apher Dial (2012) 0.99

Circulating platelet-derived microparticles with procoagulant activity may be a potential cause of thrombosis in uremic patients. Kidney Int (2002) 0.98

Association of single-nucleotide polymorphisms in the polymeric immunoglobulin receptor gene with immunoglobulin A nephropathy (IgAN) in Japanese patients. J Hum Genet (2003) 0.98

Association between single-nucleotide polymorphisms in selectin genes and immunoglobulin A nephropathy. Am J Hum Genet (2002) 0.98

Characteristics of dialysis-related amyloidosis in patients on haemodialysis therapy for more than 30 years. Nephrol Dial Transplant (2008) 0.98

Effects of sevelamer on the progression of vascular calcification in patients on chronic haemodialysis. Nephron Clin Pract (2008) 0.98

Identification, genomic organization, chromosomal mapping and mutation analysis of the human INV gene, the ortholog of a murine gene implicated in left-right axis development and biliary atresia. Hum Genet (2001) 0.97

How to manage HIV-infected patients with chronic kidney disease in the HAART era. Clin Exp Nephrol (2012) 0.97

Aortic arch calcification and arterial stiffness are independent factors for diastolic left ventricular dysfunction in chronic hemodialysis patients. Circ J (2008) 0.96

Effect of single-dose rituximab on steroid-dependent minimal-change nephrotic syndrome in adults. Nephrol Dial Transplant (2012) 0.96

Sentinel lymph node radiolocalization in clinically negative neck oral cancer. Head Neck (2006) 0.96